AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox ...

London, has collaborated with the London-based advocacy group Parkinson's In Motion and The Michael J. Fox Foundation (MJFF) ...

At Rock Steady Boxing West Michigan, patients are using boxing as a form of therapy to combat the effects of Parkinson's.

Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, ...

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

JUPITER, FL - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company with a market ...

Describing her as “nothing more than a thief,” a judge sent a Cheltenham Township woman to prison for financially exploiting an elderly Lower Gwynedd Township woman to the tune of more than ...

Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...

Bajaj Healthcare has received an approval from the Drug Controller General of India (DCGI) to manufacture both the API and Drug Formulation of Pimavanserin, a 34 mg capsule.

Bajaj Healthcare has received approval from India's Drug Controller General to manufacture Pimavanserin, a drug for Parkinson's-related hallucinations and delusions. Pimavanserin, already popular in ...